long term use of glp 1 The GLP-1 Trap: Your Jumpstart Might Be a Forever Commitment Comparing GLP‑1 Drugs With Other
Description
GLP1 receptor agonists (e.g., semaglutide) and dual GLP1 receptor agonists/GIP agonists (e.g., tirzepatide) have been shown to significantly reduce weight in patients with obesity, with and without type 2 diabetes
Liver Load Increases GLP-1 drugs are metabolically active
If third-party reliance has grown faster than oversight, that gap should be closed
These effects could be attributed to treatment with liraglutide and not to weight loss, since they were not observed in the group of animals that lost weight without receiving the GLP-1RA [40]
